The best Drug Development newsletters

Alex Kesin's blog-style newsletter examines biotech and drug development, from US-China competition in drug licensing to pharma share buybacks and the heavy-tailed revenue distributions shared by drugs and Hollywood films. Readers get long-form, opinionated analysis with data, historical context and wry commentary on industry dynamics.